Only a few days after reports emerged that the director of the FDA’s cell and gene therapy office had been abruptly put on administrative leave, a new departure shows an intense period of leadership turnover at the agency isn’t over.
read moreBIO 2025 showed the science is ready—now it’s time to ensure access, equity, and impact for patients. More: The World Can’t Wait: Delivering on the Promise of Biopharma’s “Golden Age” Mina Makar, Senior Vice President, Global Cardiovascular, Renal and Metabolism,
read moreHims & Hers stock plunged around 30% on Monday after drugmaker Novo Nordisk abruptly ended a month-long collaboration to make its weight loss drug Wegovy available on the telehealth company’s platform. More: Hims & Hers stock plunges 30% as Novo
read moreReckitt has selected Serena Williams as its doubles partner for a new plan to serve up support for health and hygiene startups around the world. More: Reckitt recruits Serena Williams for initiative to support 200 women-led health startups by 2030
read moreWith a goal of boosting its life sciences economy into the top three of the global rankings by 2035, the U.K. government is laying out six specific areas of focus to bolster its growth in the industry. More: UK lays
read more
The pilot will see GP practices look at patient records to identify those most at risk More: NHS rolls out new initiative to identify pancreatic cancer earlier Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals